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US to sue his parents for dealing him
an inferior hand of genes.
Fetuses are today commonly
screened for genetic disorders and
this service will no doubt expand. An
American company has devised a
one-inch chip carrying 400,000 DNA
fragments, which will allow the
entire human genome to be screened
for an average of four alleles per
gene. The difference between
eliminating the undesirable and
promoting the advantageous is
becoming too subtle even for ethical
hair-splitting. Those who reject the
lot as contrary to God’s will are the
descendants of the sanctimonious
bigots who sought to prevent the
application of effective treatments
for leprosy and syphilis, when these
became available earlier this century.
Nor can one argue that the new
genetic techniques signal a return to
the malign eugenics of earlier days,
for they will be driven not by the
state or any other authority but by
the aspirations of individual citizens.
Silver makes a genuflection in his
subtitle and epigraph to Aldous
Huxley, while rejecting any
comparisons with the dystopia of
Brave New World. But as the
technology will always be exacting
and expensive, genetic enhancement
will remain the prerogative of the
rich. So in time two populations will
emerge, which Silver calls the
GenRich and the Naturals, who will
seldom intermarry. The genetic
distance between the two groups will
widen until they are no longer able
to interbreed and evolution will have
been given a sharp nudge.
This (like the entire book) is
vastly entertaining stuff, but
biologists will perceive the weakness
in Silver’s jeu d’esprit: almost all
diseases, and certainly all mental and
physical attributes, are clearly
enough multigenic and interact in
complex and uncertain ways with the
environment. Silver believes that
science will in time get to grips with
all such problems; his prediction will
send shivers up many spines but not,
I suspect, those of geneticists.
Silver unexpectedly stops short of
the last frontier — the conquest of
mortality. Whether this emerges from
the study of telomeres or the
mutation in progeria or from some
other, unforeseen direction, it is
surely likely to overwhelm the
human species long before the
designer babies start to pop out of
the womb. Meanwhile, to banish the
unpleasing vision of a genetic
aristocracy poring over the DNA
stud-book, just as the inbred
nineteenth-century nobility of
Europe immersed itself endlessly in
the Almanach de Gotha, remember the
report once given by a cavalry officer
on one of his high-born subordinates:
“Personally, I would not breed from
this officer.”
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Comet sightings have often been
associated with change, sometimes
upheaval — even when the comets
in question are viewed by biologists.
Lew Tilney and Daniel Portnoy saw
comets after they infected cultured
cells with the bacterium Listeria
monocytogenes. In a number of
beautiful electron micrographs
published in the Journal of Cell
Biology in 1989 [1], Tilney and
Portnoy showed evidence that these
bacteria move by recruiting the cell’s
actin — a central component of the
cell’s own cytoskeleton — into a
structure that resembles a comet tail
behind each bacterium. 
Listeria are Gram-positive
bacteria that are commonly found in
foodstuffs, particularly unpasteurised
dairy products. For most people
Listeria are not hazardous, but
infection is a serious health problem
for pregnant women, the
immunodepressed and the elderly.
After ingestion in food, the bacteria
are taken up by the host’s
macrophages and distributed as the
infected cells circulate in the
bloodstream throughout the body.
Once inside a macrophage, the
bacteria secrete enzymes to release
themselves from the cell’s ingestion
organelle, the phagosome; the
bacteria then multiply, and move
within the macrophage until they
reach the plasma membrane and are
engulfed by other adjacent cells. By
‘hiding’ inside macrophages and
other cells, Listeria effectively avoid
the circulating antibodies of the host
while continuing to propagate. 
Although they observed static
images, Tilney and Portnoy deduced
that the actin comet tails might be
responsible for moving the bacteria
through the cell, and that studies of
Listeria might be useful to test ideas
about the everyday dynamics of the
actin cytoskeleton. Sight of these
comets led a number of laboratories
working on the actin cytoskeleton to
change direction and pursue the
problem of F-actin-directed
movement of Listeria.
The ability to form actin comets
comes from a Listeria protein, ActA,
which is expressed on the bacterial
surface. There are many unresolved
steps between the expression of ActA
protein and making an actin-filled,
force-generating comet, but it seems
clear that the bacteria use many of the
proteins that are present in normal
cellular actin-based structures. 
I missed the Tilney and Portnoy
paper in 1989, but I had had the
pleasure of attending seminars by
Tilney during several summers at the
Marine Biological Laboratory (MBL)
in Woods Hole, Massachusetts.
Among the many excellent seminars
on molecular, cellular and
developmental biology during the
Embryology course, Tilney’s — on
propulsive actin polymerization in
the sperm of the sea cucumber Thyone
— were the most memorable. He
combined seemingly simple electron
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microscopic observation with critical
thinking to clarify complex problems.
My introduction to Tilney’s
Listeria papers came when I sought a
post-doctoral position with Daniel
Louvard at the Institut Pasteur in
Paris. I had previously studied
mitosis and wanted to learn about the
behaviour of the actin cytoskeleton
during mitosis, in particular at
cytokinesis. I was directed to
Louvard’s associate, Evelyne
Friederich, who had recently set up a
project based upon studies of Listeria.
She and others transfected human
cultured cells with actA cDNAs with
dramatic effects: the cells filled up
with actin filaments and sent off
numerous membrane-bound
cytoplasmic extensions [2]. This
result suggested that human cells
have proteins that react specifically
with ActA, so they might also have a
natural ligand — a human ActA-like
protein. The research project on offer
was to identify ActA-like proteins of
human cells using ActA-specific
antibodies — a long way from my aim
of studying cytokinesis.
But the project was enticing for
several reasons. The laboratory had
considerable experience in moving
from cross-reacting antibodies to
models of how a protein might
function, and the evolutionary origins
of the actA gene were in question
because only two of the six Listeria
species carry actA — the same two
species that can form comets —
suggesting that the gene might at one
time have been acquired from another
genome, possible mammalian. But it
was a literature search on the subject
that helped close the deal. Many of
the papers on ActA cited Tilney in
their introduction, including the
seminal 1989 paper [1]. Upon reading
this paper and remembering Tilney’s
seminars at MBL, I dropped the idea
of studying cytokinesis to join
Friederich’s group and study ActA
instead.
In the 1989 paper, Tilney and
Portnoy wrote that their findings
“should be exciting to cell biologists
who want to know how actin
filaments become organised in cells”
[1]. Many authors throw in such a
phrase about their results, but this
time it was true. Studies of ActA have
already uncovered a number of
important cytoskeletal proteins: with
Mary Beckerle, we found zyxin, while
Trinad Chakraborty, Ulrich Walter
and Jürgen Wehland and colleagues
found that VASP (vasodilator
stimulated phosphoprotein) binds to
zyxin and to ActA, and the somewhat
mysterious Arp2/3 complex of
proteins resurfaced in Tim
Mitchison’s laboratory as being
required for ActA-dependent actin
polymerization — and all this was in
just the first wave of molecular
analysis of ActA.
Tilney has published other results
on unusual properties of actin
polymerization in a variety of species.
I think it’s safe to predict that there
might still be a few turning points
ahead for cell biologists who read his
papers, even if they don’t see comets.
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Correspondence
Web sequence gazing
I read The spider’s web each month
and have used much of the
information it provides, even though
I’m certainly no computer geek. I do
DNA sequencing and am hooked
into the UNIX system, but I find it
baffling and extremely user-
unfriendly. Can you can point me
towards some moderately priced
software that can be used to
manipulate DNA sequences?
Ted Barna, 16 Creekfield Drive, Sumter,
South Carolina 29154, USA.
The spider replies:
It’s a while since we last covered
sequence comparison or
bioinformatics tools in The spider’s web
but you’ll find ‘Net sequence gazing’
(Current Biology 1996, 6:103) online at
http://biomednet.com/cbiology/cub. If
you’re having trouble with UNIX,
you could try UNIXhelp for Users at
http://genome.wustl.edu/gsc/unixhelp/
Unixhelp/TOP_.html. You could also try
the following three ‘traditional’ entry
points for collections of internet links
to bioinformatics tools: Pedro’s
BioMolecular Research Tools at http://
www.biophys.uniduesseldorf.de/bionet/
research_tools.html; The WWW Virtual
Library: Biomolecules (http://
golgi.harvard.edu/sequences.html); and
Bioinformatics Resources (http://www.
genet.sickkids.on.ca/bioinfo_resources/).
Address: spider@cursci.co.uk
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A Listeria bacterium (white) and its
actin-filled comet (red) streak across the
expanse of a cytoplasmic extract prepared
from HeLa cells. Photograph courtesy of
E. Friederich, Institut Curie, Paris.
